<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/21CFR516.html">Part 516
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 516.115  Definitions.
                            </h3>
                            <p class="depth1"><em>(a)</em> The following definitions of terms apply only in the context of subpart C of this part:</p><p class="depth2">Director OMUMS means the Director of the Office of Minor Use and Minor Species Animal Drug Development of the FDA Center for Veterinary Medicine.</p><p class="depth2">Holder means the requestor of an index listing after the request is granted and the new animal drug is added to the index.</p><p class="depth2">Index means FDA's list of legally marketed unapproved new animal drugs for minor species.</p><p class="depth2">Intended use has the same meaning as that given in Sec. 516.13 of this chapter.</p><p class="depth2">Qualified expert panel means a panel that is composed of experts qualified by scientific training and experience to evaluate the target animal safety and effectiveness of a new animal drug under consideration for indexing.</p><p class="depth2">Requestor means the person making a request for determination of eligibility for indexing or a request for addition to the index.</p><p class="depth2">Transgenic animal means an animal whose genome contains a nucleotide sequence that has been intentionally modified in vitro, and the progeny of such an animal, provided that the term `transgenic animal' does not include an animal of which the nucleotide sequence of the genome has been modified solely by selective breeding.</p><p class="depth1"><em>(b)</em> The definitions of the following terms are given in Sec. 514.3 of this chapter:</p><p class="depth2">Adverse drug experience.</p><p class="depth2">Product defect/manufacturing defect.</p><p class="depth2">Serious adverse drug experience.</p><p class="depth2">Unexpected adverse drug experience.</p><p class="depth1"><em>(c)</em> The definitions of the following terms are given in Sec. 516.3 of this chapter:</p><p class="depth2">Same dosage form.</p><p class="depth2">Same drug.</p><p class="depth2">Same intended use.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§.
          Code available <a href="https://github.com/anthonygarvan/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5
      </div>
    </div>
  </footer>
  </body>
</html>
